Brain and Central Nervous System TumorsNCT00258453
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
A study testing metabolic assessment, physiologic testing and biopsy in people with Brain and Central Nervous System Tumors and Long-term Effects Secondary to Cancer Therapy in Children, run by German Society for Pediatric Oncology and Hematology GPOH gGmbH at 109 sites in 4 countries.
Trial summary
RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identify the intermediate- and long-term effects of treatment. Read more about this study
- Who is it for?
- Ages Up to 18 years
- Conditions the study is for
- Brain and Central Nervous System Tumors, Long-term Effects Secondary to Cancer Therapy in Children, Perioperative/Postoperative Complications
- What is being tested?
- metabolic assessment, physiologic testing and biopsy
- Type of treatment
- Surgery or procedure
- How many people
- 120 participants
- Where
- 109 sitesin 4 countries
- Study dates
- May 2001to Sep 2009
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
DISEASE CHARACTERISTICS:
- Diagnosis of primary craniopharyngioma by MRI and CT scan (initial diagnosis)
- Patients with only cystic sellar or parasellar malformation (e.g., Rathke pouch cysts or suprasellar cysts) are allowed but will undergo observation only
PATIENT CHARACTERISTICS:
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
PRIOR CONCURRENT THERAPY: Not specified
Trial locations and contacts
109 sites in 4 countries.
109 sites in 4 countries
Germany88 sites
Kinderklinik - Universitaetsklinikum Aachen
Aachen, D-52074
Klinikum Augsburg
Augsburg, D-86156
Caritas-Krankenhaus Bad Mergentheim
Bad Mergentheim, D-97980
Klinikum am Bamberg
Bamberg, 96049
Klinikum Bayreuth
Bayreuth, D-95445
Helios Klinikum Berlin
Berlin, 13125
Charite - Campus Charite Mitte
Berlin, D-10117
Charite University Hospital - Campus Virchow Klinikum
Berlin, D-13353
Evangelisches Krankenhauus Bielfeld
Biefeld, 33617
Kinderklinik der Universitaet Bonn
Bonn, D-53113
Klinikum Bremen-Mitte
Bremen, D-28205
Allgemeinen Krankenhaus Celle Kinderklinik
Celle, 29223
Klinikum Chemnitz gGmbH
Chemnitz, D-09116
Klinikum Coburg
Coburg, 96450
Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl
Cologne, D-50735
Children's Hospital
Cologne, D-50924
Carl - Thiem - Klinkum Cottbus
Cottbus, D-03048
Vestische Kinderklinik Universitaetsklinik Witten/Herdecke
Datteln, 45711
Klinikum Lippe - Detmold
Detmold, D-32756
Staedtisches Krankenhaus Dresden - Neustadt
Dresden, D-01129
Universitatsklinikum Carl Gustav Carus
Dresden, D-01307
Klinikum Duisburg
Duisburg, D-47055
Klinikum Erfurt
Erfurt, 99089
Universitaets - Kinderklinik
Erlangen, D-91054
Klinikum der J.W. Goethe Universitaet
Frankfurt, D-60590
Universitaetskinderklinik - Universitaetsklinikum Freiburg
Freiburg im Breisgau, D-79106
Kinderklinik
Giessen, D-35385
Universitaetsklinikum Goettingen
Göttingen, D-37075
Universitats - Kinderklinik
Greiswald, 17487
Kreiskrankenhaus Gummersbach GMBH
Gummersbach, D-51643
Universitaetsklinikum Halle
Halle, D-06097
University Medical Center Hamburg - Eppendorf
Hamburg, D-20246
Medizinische Hochschule Hannover
Hanover, D-30625
Kreskrankenhaus Kinderabteilung
Heide, 25746
Universitaets-Kinderklinik Heidelberg
Heidelberg, D-69120
SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen
Heilbronn, D-74064
Gemeinschaftskrankenhaus
Herdecke, 58313
Staedtisches Krankenhaus Hildesheim
Hildesheim, D-31134
Universitaetsklinikum des Saarlandes
Homburg, 66421
Clinic for Bone Marrow Transplantation and Hematology and Oncology
Idar-Oberstein, D-55743
Universitaets - Kinderklinik
Jena, D-07745
Municipal Hospital Complex of the University
Kaiserslautern, 67655
Staedtisches Klinikum Karlsruhe gGmbH
Karlsruhe, 76133
Klinikum Kassel
Kassel, D-34125
Staedtisches Krankenhaus Kiel
Kiel, 23116
University Hospital Schleswig-Holstein - Kiel Campus
Kiel, D-24105
Klinikum Kemperhof Koblenz
Koblenz, D-56065
Klinik Konstanz
Konstanz, 78461
Klinikum Krefeld GmbH
Krefeld, D-47805
Kinderkrankenhaus St. Marien
Landshut, 84036
Universitaets - Kinderklinik
Leipzig, D-04317
Universitaets - Kinderklinik - Luebeck
Lübeck, D-23538
St. Annastift Krankenhaus
Ludwigshafen, 67065
Universitatsklinikum der MA
Magdeburg, 39112
Johannes Gutenberg University
Mainz, D-55131
Staedtisches Klinik - Kinderklinik
Mannheim, D-68167
Universitaets - Kinderklinik
Marburg, 35033
Klinikum Minden
Minden, D-32423
Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin
Mönchengladbach, D-41066
Krankenhaus Muenchen Schwabing
Munich, 80804
Dr. von Haunersches Kinderspital der Universitaet Muenchen
Munich, D-80337
Staedtisches Krankenhaus Muenchen - Harlaching
Munich, D-81545
Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster
Münster, D-48149
Klinikum Neubrandenburg
Neubrandenburg, 17036
Lukaskrankenhaus Neuss
Neuss, D-41464
Marienhaus Klinikum St. Elisabeth Neuwied
Neuwied, 56564
Cnopf'sche Kinderklinik
Nuremberg, 90419
Klinikum Nuernberg - Klinikum Sued
Nuremberg, D-90471
Klinikum Oldenburg
Oldenburg, 26133
Marien Hospital
Osnabrück, D-49074
Paracelsus - Klinik Osnabrueck
Osnabrück, D-49076
Klinik St. Hedwig-Kinderklinik
Regensburg, 93049
Kinderklinik - Universitaetsklinikum Rostock
Rostock, D-18057
Saarbrucker Winterbergkliniken
Saarbrücken, 66119
Johanniter-Kinderklinik
Sankt Augustin, 53757
Klinikum Schwerin
Schwerin, D-19049
Kinderklink Siegen Deutsches Rotes Kreuz
Siegen, D-57072
Olgahospital
Stuttgart, D-70176
Krankenanstalt Mutterhaus der Borromaerinnen
Trier, D-54290
Universitaetsklinikum Tuebingen
Tübingen, D-72076
Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm
Ulm, D-89075
St. Marienhospital - Vechta
Vechta, D-49377
Staedtisches Klinikum - Howedestrase
Vechta, D-49377
Dr. Horst-Schmidt-Kliniken
Wiesbaden, D-65199
Reinhard-Nieter-Krankenhaus
Wilhelmshaven, D-26389
Klinikum der Stadt Wolfsburg
Wolfsburg, D-38440
Helios Kliniken Wuppertal University Hospital
Wuppertal, D-42283
Universitaets - Kinderklinik Wuerzburg
Würzburg, D-97080
Austria13 sites
Krankenhaus Dornbirn
Dornbirn, A-6850
Landeskrankenhaus Feldkirch
Feldkirch-Tisis, A-6807
Universitaet Kinderklinik
Graz, 8036
Innsbruck Universitaetsklinik
Innsbruck, A-6020
Landeskrankenhaus Klagenfurt
Klagenfurt, 9026
LKH Leoben
Leoben, A-8700
A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung
Linz, 4010
Landes-Kinderkrankenhaus
Linz, A-4020
St. Johanns-Spital
Salzburg, A-5020
Kardinal Schwarzenbersches Krankenhaus Betriebsgesellschraft mbH Kinderspital
Schwarzach, 5620
A. oe. Landeskrankenhaus Abt. fuer Kinderkrankheiten
Steyr, 4400
Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik
Vienna, 1090
St. Anna Children's Hospital
Vienna, A-1090
Switzerland7 sites
Kantonspital Aarau
Aarau, CH-5001
Universitaets-Kinderspital beider Basel
Basel, CH-4005
Ospedale "la Carita", Locarno
Locarno, 6600
Kinderspital Luzern
Lucerne, CH-6000
Ostschweizer Kinderspital
Sankt Gallen, 9006
Kantonsspital Winterthur
Winterthur, CH-8400
University Children's Hospital
Zurich, CH-8032
About this study
Official title: Prospective, Multi-Center Survey Study of Children and Adolescents With Craniopharyngioma
RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identify the intermediate- and long-term effects of treatment.
PURPOSE: This clinical trial is collecting information on diagnosis, treatment, and quality of life of young patients who are undergoing surgery for craniopharyngioma.
Read the detailed description
OBJECTIVES:
Primary
- Identify all applied therapy strategies in pediatric patients with craniopharyngioma.
- Correlate relapse status with different therapy strategies/modality in these patients.
- Determine the health status (i.e., ophthalmologic, neuropediatric, and endocrine findings) and the health-related quality of life of these patients after treatment.
Secondary
- Determine the incidence of craniopharyngioma in pediatric patients.
- Identify quality control measures for diagnosis and therapy in these patients.
- Improve long-term care through a standardized follow-up program in these patients.
- Determine the efficacy of endocrine substitution for postoperative hypopituitarism in these patients.
- Identify risk factors for developing obesity and correlate the neurotransmitter concentration of leptin and neuropeptide Y in cerebral spinal fluid, serum, and craniopharyngioma cystic fluid with the likelihood of developing obesity in these patients.
- Determine the incidence and extent of eating disorders in these patients.
OUTLINE: This is a multicenter study.
Patients undergo neurologic, endocrine, and ophthalmologic tests and anthropometric diagnostic measurements. Patients then undergo 1 of the following surgical procedures: total resection; incomplete, subtotal, or partial resection; biopsy; or cyst pressure release. Patients whose tumor relapses may undergo a second resection and/or radiotherapy.
Quality of life is assessed at baseline and then periodically thereafter.
After surgery, patients are followed periodically.
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
- Conditions
- Brain and Central Nervous System Tumors, Long-term Effects Secondary to Cancer Therapy in Children, Perioperative/Postoperative Complications, Psychosocial Effects of Cancer and Its Treatment, Weight Changes
- Being tested
- metabolic assessment, physiologic testing, biopsy, computed tomography, conventional surgery
- Keywords
- psychosocial effects of cancer and its treatment, long-term effects secondary to cancer therapy in children, perioperative/postoperative complications, weight changes, childhood craniopharyngioma
- Medical subject headings
- Central Nervous System Neoplasms, Postoperative Complications, Body Weight Changes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
metabolic assessmentOther
physiologic testingOther
biopsyProcedure or surgery
computed tomographyProcedure or surgery
conventional surgeryProcedure or surgery
magnetic resonance imagingProcedure or surgery
management of therapy complicationsProcedure or surgery
psychosocial assessment and careProcedure or surgery
quality-of-life assessmentProcedure or surgery
radiation therapyRadiation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Nov 2005 (estimated)
- Study startMay 2001
- Primary completionSep 2007
- Study completionSep 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (12)Papers the sponsor has linked to this study.
- Other trials for Brain and Central Nervous System TumorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- German Society for Pediatric Oncology and Hematology GPOH gGmbH
- Sponsor type
- University, hospital or other
- Investigators
- Hermann Mueller, MD, Study chair, Klinikum Oldenburg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00258453
- Sponsor's protocol ID
- GPOH-CRANIOPHARYNGIOMA-2000
- Other IDs
- CDR0000450768, EU-20537
- Status last verified
- Oct 2007
- First submitted
- 22 Nov 2005
- Last updated
- 2 Aug 2013
- Results posted
- No
Publications
Roth CL, Gebhardt U, Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring). 2011 Jan;19(1):36-42. doi: 10.1038/oby.2010.80. Epub 2010 Apr 8.
PubMed 20379145Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N; study committee of KRANIOPHARYNGEOM 2000/2007. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr. 2010;73(3):175-80. doi: 10.1159/000284358. Epub 2010 Mar 3.
PubMed 20197669Sowithayasakul P, Beckhaus J, Ozyurt J, Bison B, Friedrich C, Muller HL. Prolactin serum concentrations in childhood-onset craniopharyngioma patients. J Endocrinol Invest. 2025 Sep;48(9):2041-2051. doi: 10.1007/s40618-025-02622-4. Epub 2025 Jun 7.
PubMed 40481916Mann-Markutzyk LV, Beckhaus J, Ozyurt J, Mehren A, Friedrich C, Muller HL. Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma. Sci Rep. 2025 Mar 19;15(1):9407. doi: 10.1038/s41598-025-94384-5.
PubMed 40108339Wagener K, Beckhaus J, Boekhoff S, Friedrich C, Muller HL. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents. J Neurooncol. 2023 Jul;163(3):555-563. doi: 10.1007/s11060-023-04344-0. Epub 2023 Jul 4.
PubMed 37402092Beckhaus J, Friedrich C, Boekhoff S, Calaminus G, Bison B, Eveslage M, Timmermann B, Flitsch J, Muller HL. Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage. Eur J Endocrinol. 2023 Mar 2;188(3):lvad027. doi: 10.1093/ejendo/lvad027.
PubMed 36857103Mehren A, Ozyurt J, Zu Klampen P, Boekhoff S, Thiel CM, Muller HL. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol. 2018 Oct;140(1):27-35. doi: 10.1007/s11060-018-2936-z. Epub 2018 Jul 3.
PubMed 29971569Ozyurt J, Muller HL, Warmuth-Metz M, Thiel CM. Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex. 2017 Apr;89:98-110. doi: 10.1016/j.cortex.2017.01.017. Epub 2017 Feb 3.
PubMed 28259055Daubenbuchel AM, Hoffmann A, Eveslage M, Ozyurt J, Lohle K, Reichel J, Thiel CM, Martens H, Geenen V, Muller HL. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine. 2016 Nov;54(2):524-531. doi: 10.1007/s12020-016-1084-5. Epub 2016 Sep 1.
PubMed 27585663Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbuchel AM, Sterkenburg AS, Muller HL. Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary. 2016 Aug;19(4):422-8. doi: 10.1007/s11102-016-0722-5.
PubMed 27125511Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Muller HL. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014 Apr;164(4):876-881.e4. doi: 10.1016/j.jpeds.2013.12.010. Epub 2014 Feb 6.
PubMed 24507865Roth CL, Enriori PJ, Gebhardt U, Hinney A, Muller HL, Hebebrand J, Reinehr T, Cowley MA. Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metabolism. 2010 Feb;59(2):186-94. doi: 10.1016/j.metabol.2009.06.031. Epub 2009 Sep 18.
PubMed 19766264
Study at a glance
From the registry record, last updated by the sponsor on 2 Aug 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective, Multi-Center Survey Study of Children and Adolescents With Craniopharyngioma
- ClinicalTrials.gov ID
- NCT00258453
- Acronym / sponsor ID
- GPOH-CRANIOPHARYNGIOMA-2000
- Conditions
- Brain and Central Nervous System Tumors, Long-term Effects Secondary to Cancer Therapy in Children, Perioperative/Postoperative Complications, Psychosocial Effects of Cancer and Its Treatment, Weight Changes
- Keywords
- psychosocial effects of cancer and its treatment, long-term effects secondary to cancer therapy in children, perioperative/postoperative complications, weight changes, childhood craniopharyngioma
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- German Society for Pediatric Oncology and Hematology GPOH gGmbHUniversity, hospital or other
- Study start
- May 2001
- Primary completion
- Sep 2007 (actual)
- Study completion
- Sep 2009 (actual)
- First posted
- 24 Nov 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identify the intermediate- and long-term effects of treatment.
PURPOSE: This clinical trial is collecting information on diagnosis, treatment, and quality of life of young patients who are undergoing surgery for craniopharyngioma.
Detailed description
OBJECTIVES:
Primary
- Identify all applied therapy strategies in pediatric patients with craniopharyngioma.
- Correlate relapse status with different therapy strategies/modality in these patients.
- Determine the health status (i.e., ophthalmologic, neuropediatric, and endocrine findings) and the health-related quality of life of these patients after treatment.
Secondary
- Determine the incidence of craniopharyngioma in pediatric patients.
- Identify quality control measures for diagnosis and therapy in these patients.
- Improve long-term care through a standardized follow-up program in these patients.
- Determine the efficacy of endocrine substitution for postoperative hypopituitarism in these patients.
- Identify risk factors for developing obesity and correlate the neurotransmitter concentration of leptin and neuropeptide Y in cerebral spinal fluid, serum, and craniopharyngioma cystic fluid with the likelihood of developing obesity in these patients.
- Determine the incidence and extent of eating disorders in these patients.
OUTLINE: This is a multicenter study.
Patients undergo neurologic, endocrine, and ophthalmologic tests and anthropometric diagnostic measurements. Patients then undergo 1 of the following surgical procedures: total resection; incomplete, subtotal, or partial resection; biopsy; or cyst pressure release. Patients whose tumor relapses may undergo a second resection and/or radiotherapy.
Quality of life is assessed at baseline and then periodically thereafter.
After surgery, patients are followed periodically.
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
Study design
- Primary purpose
- Diagnosis
- Masking
- None (open label)
Who may qualify
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| metabolic assessment | Other | – |
| physiologic testing | Other | – |
| biopsy | Procedure or surgery | – |
| computed tomography | Procedure or surgery | – |
| conventional surgery | Procedure or surgery | – |
| magnetic resonance imaging | Procedure or surgery | – |
| management of therapy complications | Procedure or surgery | – |
| psychosocial assessment and care | Procedure or surgery | – |
| quality-of-life assessment | Procedure or surgery | – |
| radiation therapy | Radiation | – |
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Aug 2013.
- Results publication: PubMed 20379145Roth CL, Gebhardt U, Muller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring). 2011 Jan;19(1):36-42. doi: 10.1038/oby.2010.80. Epub 2010 Apr 8.
- Results publication: PubMed 20197669Muller HL, Gebhardt U, Schroder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sorensen N; study committee of KRANIOPHARYNGEOM 2000/2007. Analyses of treatment variables for patients with childhood craniopharyngioma--results of the multicenter prospective trial KRANIOPHARYNGEOM 2000 after three years of follow-up. Horm Res Paediatr. 2010;73(3):175-80. doi: 10.1159/000284358. Epub 2010 Mar 3.
- Derived from this study: PubMed 40481916Sowithayasakul P, Beckhaus J, Ozyurt J, Bison B, Friedrich C, Muller HL. Prolactin serum concentrations in childhood-onset craniopharyngioma patients. J Endocrinol Invest. 2025 Sep;48(9):2041-2051. doi: 10.1007/s40618-025-02622-4. Epub 2025 Jun 7.
- Derived from this study: PubMed 40108339Mann-Markutzyk LV, Beckhaus J, Ozyurt J, Mehren A, Friedrich C, Muller HL. Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma. Sci Rep. 2025 Mar 19;15(1):9407. doi: 10.1038/s41598-025-94384-5.
- Derived from this study: PubMed 37402092Wagener K, Beckhaus J, Boekhoff S, Friedrich C, Muller HL. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents. J Neurooncol. 2023 Jul;163(3):555-563. doi: 10.1007/s11060-023-04344-0. Epub 2023 Jul 4.
- Derived from this study: PubMed 36857103Beckhaus J, Friedrich C, Boekhoff S, Calaminus G, Bison B, Eveslage M, Timmermann B, Flitsch J, Muller HL. Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage. Eur J Endocrinol. 2023 Mar 2;188(3):lvad027. doi: 10.1093/ejendo/lvad027.
- Derived from this study: PubMed 29971569Mehren A, Ozyurt J, Zu Klampen P, Boekhoff S, Thiel CM, Muller HL. Self- and informant-rated apathy in patients with childhood-onset craniopharyngioma. J Neurooncol. 2018 Oct;140(1):27-35. doi: 10.1007/s11060-018-2936-z. Epub 2018 Jul 3.
- Derived from this study: PubMed 28259055Ozyurt J, Muller HL, Warmuth-Metz M, Thiel CM. Hypothalamic tumors impact gray and white matter volumes in fronto-limbic brain areas. Cortex. 2017 Apr;89:98-110. doi: 10.1016/j.cortex.2017.01.017. Epub 2017 Feb 3.
- Derived from this study: PubMed 27585663Daubenbuchel AM, Hoffmann A, Eveslage M, Ozyurt J, Lohle K, Reichel J, Thiel CM, Martens H, Geenen V, Muller HL. Oxytocin in survivors of childhood-onset craniopharyngioma. Endocrine. 2016 Nov;54(2):524-531. doi: 10.1007/s12020-016-1084-5. Epub 2016 Sep 1.
- Derived from this study: PubMed 27125511Hoffmann A, Warmuth-Metz M, Lohle K, Reichel J, Daubenbuchel AM, Sterkenburg AS, Muller HL. Fusiform dilatation of the internal carotid artery in childhood-onset craniopharyngioma: multicenter study on incidence and long-term outcome. Pituitary. 2016 Aug;19(4):422-8. doi: 10.1007/s11102-016-0722-5.
- Derived from this study: PubMed 24507865Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Muller HL. Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr. 2014 Apr;164(4):876-881.e4. doi: 10.1016/j.jpeds.2013.12.010. Epub 2014 Feb 6.
- Derived from this study: PubMed 19766264Roth CL, Enriori PJ, Gebhardt U, Hinney A, Muller HL, Hebebrand J, Reinehr T, Cowley MA. Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metabolism. 2010 Feb;59(2):186-94. doi: 10.1016/j.metabol.2009.06.031. Epub 2009 Sep 18.
Related trials for Brain and Central Nervous System Tumors
RecruitingPhase 2
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
Triple-Negative Breast Cancer (TNBC), Brain Metastases
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
RecruitingPhase 1/2
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Glioma, Medulloblastoma
Recruiting
Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors
Cancer-related Cognitive Dysfunction, Primary Brain Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hermann Mueller, MD study chair
Klinikum Oldenburg
109 sites in 4 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing metabolic assessment, physiologic testing and biopsy in people with Brain and Central Nervous System Tumors and Long-term Effects Secondary to Cancer Therapy in Children, run by German Society for Pediatric Oncology and Hematology GPOH gGmbH at 109 sites in 4 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 109 sites in Germany, Austria, Switzerland, Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00258453, which also lists 12 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2013.